Latest filings (excl ownership)
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
8-K
Termination of a Material Definitive Agreement
19 Apr 24
10-K/A
2023 FY
Annual report (amended)
17 Apr 24
8-K
Entry into a Material Definitive Agreement
17 Apr 24
8-K
INVO Reports Fourth Quarter and Full Year 2023 Financial Results
16 Apr 24
10-K
2023 FY
Annual report
16 Apr 24
8-K
Entry into a Material Definitive Agreement
11 Apr 24
8-K/A
Entry into a Material Definitive Agreement
2 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Entry into a Material Definitive Agreement
1 Apr 24
424B5
Prospectus supplement for primary offering
29 Mar 24
10-K/A
2022 FY
Annual report (amended)
27 Mar 24
8-K
Entry into a Material Definitive Agreement
1 Mar 24
8-K
Other Events
1 Feb 24
S-4
Registration of securities issued in business combination transactions
16 Jan 24
8-K/A
Entry into a Material Definitive Agreement
10 Jan 24
8-K
Entry into a Material Definitive Agreement
10 Jan 24
8-K
Entry into a Material Definitive Agreement
3 Jan 24
424B7
Prospectus with selling stockholder info
28 Dec 23
8-K
Entry into a Material Definitive Agreement
28 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
27 Dec 23
DEFA14A
Additional proxy soliciting materials
13 Dec 23
8-K
Amendments to Articles of Incorporation or Bylaws
13 Dec 23
8-K
Other Events
28 Nov 23
DEF 14A
Definitive proxy
24 Nov 23
8-K
Entry into a Material Definitive Agreement
20 Nov 23
8-K
INVO Reports Record Third Quarter 2023 Financial Results
13 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
SC TO-C
Information about tender offer
13 Nov 23
8-K
Other Events
13 Nov 23
PRE 14A
Preliminary proxy
13 Nov 23
8-K
INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company’s Common Stock Purchase Warrants
9 Nov 23
8-K
INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
26 Oct 23
8-K
Other Events
24 Oct 23
8-K
Amendments to Articles of Incorporation or Bylaws
16 Oct 23
8-K
Entry into a Material Definitive Agreement
5 Oct 23
8-K
Other Events
3 Oct 23
DEFA14A
Additional proxy soliciting materials
2 Oct 23
8-K
Invo Bioscience Announces Adjournment of Special Meeting of Shareholders
29 Sep 23
DEFA14A
Additional proxy soliciting materials
28 Sep 23
Latest ownership filings
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
SC 13G/A
AWM Investment Company, Inc.
8 Sep 23
SC 13G
INTRACOASTAL CAPITAL, LLC
11 Aug 23
4
Matthew K Szot
22 May 23
4
Steve Shum
22 May 23
4
Barbara Ryan
22 May 23
4
Rebecca Messina
22 May 23
4
Andrea Goren
22 May 23
4
TRENT D DAVIS
22 May 23
4
Michael Jos. Campbell
22 May 23
SC 13G/A
AWM Investment Company, Inc.
14 Feb 23
4
Steve Shum
3 Jun 22
4
Matthew K Szot
3 Jun 22
4
Barbara Ryan
3 Jun 22
4
TRENT D DAVIS
3 Jun 22
4
Jeffrey Segal
3 Jun 22
4
Michael Jos. Campbell
3 Jun 22
4
Andrea Goren
3 Jun 22
4
Rebecca Messina
3 Jun 22
4
Kevin Doody
3 Jun 22
SC 13G
Ranoux Claude
22 Feb 22
SC 13G/A
AWM Investment Company, Inc.
11 Feb 22
4
TRENT D DAVIS
18 Jan 22
4
Kevin Doody
18 Jan 22
4
Jeffrey Segal
18 Jan 22
4
Michael Jos. Campbell
18 Jan 22
4
Steve Shum
18 Jan 22
4
Matthew K Szot
18 Jan 22
4
Rebecca Messina
18 Jan 22
4
Barbara Ryan
18 Jan 22
4
Andrea Goren
18 Jan 22
4
Change in insider ownership
12 Oct 21
4
Andrea Goren
7 Oct 21
4
Steve Shum
7 Oct 21
3
Andrea Goren
21 Jun 21
4
Rebecca Messina
13 May 21
4
Change in insider ownership
12 May 21
4
Change in insider ownership
11 May 21
SC 13G/A
AWM Investment Company, Inc.
11 May 21
3
Initial statement of insider ownership
11 May 21